# Pharmaline · 99-39 · CANADA — FDA import alert red lists: firms subject to detention without physical examination

For Pharmaline · 99-39 · CANADA, import alert is 99-39; import alert name is Detention Without Physical Examination of Imported Food Products That Appear to Be Misbranded; country is CANADA; product is FULVIC CARE POWDER; product code is 54 Y - - 99 Vitamin, Mineral, Proteins and Unconventional Dietary Specialities For Humans and Animals, N.E.C; date published is 12/10/2021; address is 2835 Argentia Rd Unit 5 , Mississauga, Ontario CANADA, verified against its source on 2026-09-16.

- **Firm:** Pharmaline _(verified: appears in the quote below)_
- **Import alert:** 99-39
- **Import alert name:** Detention Without Physical Examination of Imported Food Products That Appear to Be Misbranded
- **Country:** CANADA _(verified: appears in the quote below)_
- **Address:** 2835 Argentia Rd Unit 5 , Mississauga, Ontario CANADA _(verified: appears in the quote below)_
- **Date published:** 12/10/2021 _(verified: appears in the quote below)_
- **Product code:** 54 Y - - 99 Vitamin, Mineral, Proteins and Unconventional Dietary Specialities For Humans and Animals, N.E.C. _(verified: appears in the quote below)_
- **Product:** FULVIC CARE POWDER _(verified: appears in the quote below)_
- **FDA notes:** The article is subject to refusal of admission pursuant to Section 801(a)(3) of the Federal Food Drug, and Cosmetic Act (FD&C Act) in that it appears to be misbranded within the meaning of: Section 403(a)(1) of the FD&C Act in that the labeling is false or misleading. The product does not contain the declared amount of vitamin C. Section 403 (e)(1) food is in package form and the label fails to bear the name and place of business of the manufacturer, packer, or distributor. Section 403 (q) in that the label or labeling fails to bear the required nutrition information For example, the product label fails to declare the amount of potassium using the correct unit of measure given in 21 CFR 101.9(c)(8)(iv) as required by 21 CFR 101.36(b)(2)(ii)(B). The article appears to be misbranded within the meaning of section 403(q)(1)(B) of the Act [21 U.S.C. § 343(q)(1)(B)] because it fails to declare the servings per container in accordance with 21 CFR 101.36(b)(1)(ii). The article appears to be misbranded within the meaning of section 403(e)(2) of the Act [21 U.S.C. § 343(e)(2)] because the label fails to correctly declare the net quantity of contents on the principal display panel as required by 21 CFR 101.7. Section 403(r)(1)(A)/(B) in that the label or labeling bears an unauthorized nutrient content/health claim Specifically, the label claims “This product is an excellent source of organic fulvic acid, humic acid, trace minerals, electrolytes, & antioxidants.” Section 403(s)(2)(B) of the FD&C Act in that the label or labeling fails to identify the product by using the term "dietary supplement," which term may be modified with the name of such an ingredient. Section 403(y) of the FD&C Act in that the dietary supplement label fails to bear a domestic address or phone number through which the responsible person (as described in section 761 of the FD&C Act) may receive a report of a serious adverse event with such dietary supplement. _(verified: appears in the quote below)_

## What the source says

> Pharmaline Date Published : 12/10/2021 2835 Argentia Rd Unit 5 , Mississauga, Ontario CANADA 54 Y - - 99 Vitamin, Mineral, Proteins and Unconventional Dietary Specialities For Humans and Animals, N.E.C. Date Published: 12/10/2021 Desc: FULVIC CARE POWDER Notes: The article is subject to refusal of admission pursuant to Section 801(a)(3) of the Federal Food Drug, and Cosmetic Act (FD&C Act) in that it appears to be misbranded within the meaning of: Section 403(a)(1) of the FD&C Act in that the labeling is false or misleading. The product does not contain the declared amount of vitamin C. Section 403 (e)(1) food is in package form and the label fails to bear the name and place of business of the manufacturer, packer, or distributor. Section 403 (q) in that the label or labeling fails to bear the required nutrition information For example, the product label fails to declare the amount of potassium using the correct unit of measure given in 21 CFR 101.9(c)(8)(iv) as required by 21 CFR 101.36(b)(2)(ii)(B). The article appears to be misbranded within the meaning of section 403(q)(1)(B) of the Act [21 U.S.C. § 343(q)(1)(B)] because it fails to declare the servings per container in accordance with 21 CFR 101.36(b)(1)(ii). The article appears to be misbranded within the meaning of section 403(e)(2) of the Act [21 U.S.C. § 343(e)(2)] because the label fails to correctly declare the net quantity of contents on the principal display panel as required by 21 CFR 101.7. Section 403(r)(1)(A)/(B) in that the label or labeling bears an unauthorized nutrient content/health claim Specifically, the label claims “This product is an excellent source of organic fulvic acid, humic acid, trace minerals, electrolytes, & antioxidants.” Section 403(s)(2)(B) of the FD&C Act in that the label or labeling fails to identify the product by using the term "dietary supplement," which term may be modified with the name of such an ingredient. Section 403(y) of the FD&C Act in that the dietary supplement label fails to bear a domestic address or phone number through which the responsible person (as described in section 761 of the FD&C Act) may receive a report of a serious adverse event with such dietary supplement.

## Source

- https://www.accessdata.fda.gov/cms_ia/importalert_1144.html

Last verified: 2026-09-16. Review by: 2026-11-15.
Part of [FDA import alert red lists: firms subject to detention without physical examination](https://referencesource.org/fda-import-alert-red-list/).